New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Sanofi

SNY

Healthcare Drug Manufacturers General

Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024.

Revenue
+13.9%
EPS
+8.21%
Free cash flow
+99.6%
Total debt
−11.2%

Quarter to September 2026, against a year earlier

46.59 0.53 +1.15%
Market cap
$111.3B
P/E
22.8×
Fwd P/E FY26e
—
Dividend yield
5.25%
F-score
7/9
ROIC
7.05%
Net debt / EBITDA
0.8×
Payout ratio
1.2×

Sanofi (SNY) EV/Sales

Alert me on EV/Sales

As of Nov 19, 2026, Sanofi (SNY) trades at a EV/Sales of 2.1×. Over the past ten years it has ranged from 1.8× (September 2022) to 3.5× (August 2015); the current reading is higher than 10% of that period. That is below the Drug Manufacturers General industry median of 4.1× and below the Healthcare sector median of 3.3×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.5× (8.86%)
FY2024 2.7× 2.14%
FY2023 2.7× (1.80%)
FY2022 2.7× 30.01%
FY2021 2.1× (0.78%)
FY2020 2.1× (10.02%)
FY2019 2.3× (4.65%)
FY2018 2.4× (12.96%)
FY2017 2.8× (6.04%)
FY2016 3.0× 5.05%

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.9× (9.39%)
Jun 2026 2.1× (11.78%)
Mar 2026 2.4× (3.46%)
Dec 2025 2.5× (9.54%)
39 more quarters

Against its own ten years

Low 1.8× High 3.5×
Ten-year median 2.6×
Current reading's percentile 11

EV/Sales against peers

Company EV/Sales
SNY Sanofi 2.1×
GSK GSK PLC Sponsored ADR compare 2.8×
BMY Bristol Myers Squibb Company compare 3.0×
PFE Pfizer Inc. compare 3.2×
NVO Novo Nordisk A/S compare 3.6×
AZN AstraZeneca PLC compare 4.7×
NVS Novartis AG compare 5.6×
AMGN Amgen Inc. compare 7.2×
GILD Gilead Sciences, Inc. compare 7.3×
Drug Manufacturers General industry median 4.1×
Healthcare sector median 3.3×
Market median 2.0×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on SNY